Premium
Bone Loss in Thyroid Disease
Author(s) -
ABE ETSUKO,
SUN LI,
MECHANICK JEFFREY,
IQBAL JAMEEL,
YAMOAH KOSJ,
BALIRAM RAMKUMARIE,
ARABI ARIO,
MOONGA BALJIT S.,
DAVIES TERRY F.,
ZAIDI MONE
Publication year - 2007
Publication title -
annals of the new york academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.712
H-Index - 248
eISSN - 1749-6632
pISSN - 0077-8923
DOI - 10.1196/annals.1402.062
Subject(s) - medicine , subclinical infection , thyroid , osteoporosis , hormone , hormone replacement , bone remodeling , hormone replacement therapy (female to male) , thyroid disease , disease , endocrinology , physiology , testosterone (patch)
: More than 10% of postmenopausal women in the United States receive thyroid hormone replacement therapy and up to 20% of these women are over‐replaced inducing subclinical hyperthyroidism. Because hyperthyroidism and post menopausal osteoporosis overlap in women of advancing age, it is urgent to understand the effect of thyroid hormone excess on bone. We can now provide results that not thyroid hormones but also TSH itself has an equally important role to play in bone remodeling.